Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
American Journal of Epidemiology|October 15, 2020
Leveraging Technology to Blend Large-Scale Epidemiologic Surveillance With Social and Behavioral Science Methods: Successes, Challenges, and Lessons Learned Implementing the UNITE Longitudinal Cohort Study of HIV Risk Factors Among Sexual Minority Men in the United StatesH Jonathon Rendina, Ali J Talan, Nicola F Tavella, et al.
Pediatric Neurology|August 20, 2013
National variation in costs and mortality for leukodystrophy patients in US children's hospitalsCameron J Brimley, Jonathan Lopez, Keith van Haren, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|August 18, 2020
Cytological features and nuclear scores: Diagnostic tools in preoperative fine needle aspiration of indeterminate thyroid nodules with RAS or BRAF K601E mutations?Lucie Ravella, Jonathan Lopez, Françoise Descotes, et al.
Gynecologic Oncology|June 10, 2020
Transcriptomic and immunohistochemical approaches identify HLA-G as a predictive biomarker of gestational choriocarcinoma resistance to monochemotherapyPierre-Adrien Bolze, Jonathan Lopez, Fabienne Allias, et al.
Histopathology|May 6, 2024
Peculiar nuclear atypia associated with MDM2 gene amplification in carcinoma ex-pleomorphic adenoma harbouring an alteration of HMGA2Ziyad Alsugair, Maxime Fieux, Françoise Descotes, et al.
EMBO Reports|May 21, 2011
Antagonistic regulation of EMT by TIF1γ and Smad4 in mammary epithelial cellsCédric Hesling, Laurent Fattet, Guillaume Teyre, et al.
Histopathology|September 29, 2023
Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovariiSophie Neyrand, Alexis Trecourt, Jonathan Lopez, et al.
Biomedicines|January 21, 2023
Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective StudyMadeleine Maugeais, Julien Péron, Stéphane Dalle, et al.
Endocrine Oncology (Bristol, England)|July 12, 2023
cfDNA in pancreatic neuroendocrine carcinoma management with Cushing's syndromeLaura Gerard, David Barthelemy, Arnaud Gauthier, et al.
Oncogene|February 19, 2020
The apoptosis inhibitor Bcl-xL controls breast cancer cell migration through mitochondria-dependent reactive oxygen species productionMargaux Bessou, Jonathan Lopez, Rudy Gadet, et al.
Pageof 11